β-Adrenergic receptor expression in vascular tumors (Q60152692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

β-Adrenergic receptor expression in vascular tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kay W. Chang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Mai T Truong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Shirley Kwok

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Rob B West

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Amy E Heerema-McKenney

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

29 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1446-1451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

cites work

Hemangiomas of infancy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

[Vincristine treatment for function- and life-threatening infantile hemangioma]

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Treatment of life-threatening infantile hemangiomas with vincristine.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Effective therapy of a vascular tumor of infancy with vincristine

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Complications of systemic corticosteroid therapy for problematic hemangioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Toxicity profile of interferon alfa-2b in children: A prospective evaluation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Propranolol for severe hemangiomas of infancy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Beta-blocking agent for treatment of infantile hemangioma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Propranolol for severe infantile hemangiomas: follow-up report

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Propranolol treatment for infantile hemangiomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Propranolol as first-line treatment for infantile hemangiomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: case report and literature review.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Beta-adrenoceptor subtypes and their desensitization mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

The beta-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Cellular markers that distinguish the phases of hemangioma during infancy and childhood

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

Propranolol for the treatment of airway hemangiomas: A case series and treatment algorithm

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.108

7 January 2021

10.1038/MODPATHOL.2012.108

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22743651%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference